focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

AGM Statement

19 Jun 2012 07:00

RNS Number : 6334F
Phorm Inc
19 June 2012
 



19 June 2012

Phorm, Inc. ('Phorm' or 'the Company')

AGM Statement

 

At the Annual General Meeting of the Company to be held at 11.00am today, Kent Ertugrul, CEO of Phorm, will make the following statement:

"I'm pleased to be able to inform investors that significant progress has been made on all the opportunities highlighted to investors last October. It has taken longer than expected to achieve, but the outcome is very significant. On 1 June 2012 we announced an equity fundraising into our Chinese business which valued that opportunity alone at £100m. This is extremely significant and represents a giant step forward in that region.

Today I am pleased to announce further details of our intention to re-domicile the holding company of the group from Delaware in order to simplify the trading mechanics around the Company's shares and enhance their liquidity.

It is intended to undertake a corporate reorganisation to form a new holding company ("New Topco") for the group, incorporated outside the US in Singapore. As a result of the reorganisation, current shareholders will receive one share of the New Topco subsidiary for each share of Phorm Inc they currently own. The redomiciliation will be subject to shareholder approval, and various tax and regulatory clearances. We expect to post the appropriate documentation to shareholders in the next two months and will make a further announcement at that point.

So far this financial year the future prospects of the Company have been materially enhanced by the huge amount of work done behind the scenes and we look forward to announcing a number of further commercial launches during this financial year."

For Enquiries

 

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

 

- ends -

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

 

For more information, please visit: www.phorm.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBKFDNCBKDBAD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.